Influenza Clinical Trial
Official title:
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
Background:
- The flu is a very infectious and contagious virus that affects both people and pigs.
Studies show that pigs can be sources of the flu virus in humans. Researchers want to know
more about how the flu is transmitted from animals to people. If they know more about it,
they can find better ways to prevent the flu and treat people who get sick from it.
Objective:
- To discover if flu viruses can be found in people exposed to pigs at Ohio agricultural
fairs.
Eligibility:
- Volunteers 8 years of age and older who exhibit pigs at Ohio agricultural fairs.
Design:
- Before or on the first day of the fair, participants will fill out a short demographic
and medical history form. They will also complete a two-page symptom questionnaire. This
is a form that asks them about any flu symptoms they might have.
- Participants will have a nasal swab performed. The inside of the participant s nose will
be rubbed with a swab to collect nasal fluid.
- Researchers will see participants 2 days later and 4 days later. During these visits,
participants will again fill out a symptom questionnaire and have a nasal swab.
The bidirectional transmission of influenza A viruses between animals and humans are clearly
an important part of the complex dynamics of influenza evolution, however a thorough
understanding of this process remains a mystery. The role of swine in overall human influenza
evolution is unclear, but a long history of the study of swine origin influenza has revealed
that influenza evolves in swine populations both in North America and Europe.
In 2009, a pandemic occurred with the emergence of the H1N1 pandemic (pdm) virus which was
found to have originated from both a North American and European swine lineage, again
reinforcing how viruses evolving in swine can lead to important human pathogens.
Interestingly this virus was transmitted back into swine and birds in North America. In 2011,
an H3N2 swine origin influenza virus known as the H3N2v and containing the H1N1pdm matrix
genomic segment was reported causing human infections in multiple parts of the US. In 2012,
these cases increased, especially during the summer months. Since 2011, 321 confirmed cases
have been reported from 13 states including 107 cases in Ohio. Almost all of these cases have
been linked to swine exposure on farms or at agricultural fairs.
Study of these zoonotic transmission events at agricultural fairs are necessary in order to
better understand how and why these events occur, how human pathogens emerge, and how to
potentially prevent events from occurring. These events could lead to new pandemics and
epidemics so their prevention is crucial. The goal of this study is to examine rates of
bidirectional zoonotic transmission at Ohio agricultural fairs. Through collection of viruses
and host samples, we hope to begin to answer questions regarding how viruses cross species
barriers, adapt to new hosts, and how these events could impact overall influenza virus
evolution.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |